Trails Edge Capital Partners, Lp
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$436.5M
Q ending 2026-03-31
Prior quarter
$404.7M
Q ending 2025-12-31
Change
+7.9% QoQ
Positions
27
reported holdings
Largest positions
All 27 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Vaxcyte Inc | PCVX | Shares | $38.5M | 662K |
| Definium Therapeutics Inc | DFTX | Shares | $32.9M | 1.7M |
| Lb Pharmaceuticals Inc | LBRX | Shares | $32.5M | 1.3M |
| Mirum Pharmaceuticals Inc | MIRM | Shares | $30.8M | 333K |
| Nurix Therapeutics Inc | NRIX | Shares | $27.0M | 1.7M |
| Xenon Pharmaceuticals Inc | XENE | Shares | $25.6M | 440K |
| Revolution Medicines Inc | RVMD | Shares | $23.8M | 245K |
| Arcus Biosciences Inc | RCUS | Shares | $22.6M | 1.0M |
| Immunocore Hldgs Plc | IMCR | Shares | $20.6M | 683K |
| Cytokinetics Inc | CYTK | Shares | $19.8M | 300K |
| Syndax Pharmaceuticals Inc | SNDX | Shares | $16.4M | 702K |
| Neurogene Inc | NGNE | Shares | $15.8M | 783K |
| Inventiva Sa | IVA | Shares | $14.8M | 2.7M |
| Inhibikase Therapeutics Inc | IKT | Shares | $13.5M | 8.1M |
| 4D Molecular Therapeutics In | FDMT | Shares | $12.1M | 1.3M |
| Xenon Pharmaceuticals Inc | XENE | Put | $11.6M | 200K |
| X4 Pharmaceuticals Inc | XFOR | Shares | $10.6M | 2.6M |
| Immunovant Inc | IMVT | Shares | $10.3M | 414K |
| Design Therapeutics Inc | DSGN | Shares | $9.1M | 852K |
| Camp4 Therapeutics Corp | CAMP | Shares | $8.6M | 1.9M |
| Minerva Neurosciences Inc | NERV | Shares | $8.5M | 1.4M |
| Promis Neurosciences Inc | PMN | Shares | $7.1M | 557K |
| Sol-Gel Technologies Ltd | Shares | $6.8M | 85K | |
| Century Therapeutics Inc | IPSC | Shares | $5.5M | 2.4M |
| Vtv Therapeutics Inc | VTVT | Shares | $5.5M | 140K |
| Sensei Biotherapeutics Inc | FTH | Shares | $3.9M | 125K |
| Opus Genetics Inc | IRD | Shares | $2.3M | 500K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.